Aqua Bio Technology: Notice of extraordinary general meeting

An extraordinary general meeting of Aqua Bio Technology ASA (the "Company" or "ABTEC") will be held on 9 April 2025 at 10:00 (CET) at Advokatfirmaet CLP DA, Sommerrogata 13-15, 0255 Oslo. Please find attached the notice to the general meeting. All documents to be treated at the general meeting will be made available at the Company's website www.aquabiotechnology.com - http://www.aquabiotechnology.com.

 

Shareholders who wish to the attend the general meeting is requested to notify the Company as set out in Appendix 1 to the notice within 7 April 2025 at 16:00 (CET). In case of attendance by proxy, the proxy form (also included in appendix 1 to the notice) is requested submitted to be received by the Company within the same date.

 

For further information, please contact

Fredrik Henriksen, CEO

Phone +47 900 20 078

 

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective, and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange.

 

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.